sivelestat has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hihara, J; Konishi, K; Mizuiri, H; Suzuki, T; Tanabe, K; Taomoto, J; Ukon, K; Wada, Y; Yoshida, K | 1 |
| Ando, M; Ashihara, Y; Fukami, T; Hiroshige, S; Kumamoto, T; Miyazaki, E; Noguchi, T; Ohishi, K; Okubo, T; Sugisaki, K; Tsuda, T; Ueo, M; Yoshitake, S | 1 |
2 other study(ies) available for sivelestat and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-alpha.
Topics: Animals; Carcinoma; ErbB Receptors; Female; Glycine; Humans; Leukocyte Elastase; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 3; Neoplasm Transplantation; Phosphorylation; Serine Proteinase Inhibitors; Stomach Neoplasms; Sulfonamides; Transforming Growth Factor alpha; Xenograft Model Antitumor Assays | 2006 |
Virus associated hemophagocytic syndrome accompanied by acute respiratory failure caused by influenza A (H3N2).
Topics: Acute Kidney Injury; Adult; Antibodies, Viral; Bronchi; Carcinoma; Combined Modality Therapy; Female; gamma-Globulins; Glycine; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Immunosuppressive Agents; Influenza A Virus, H3N2 Subtype; Influenza, Human; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Myocarditis; Postoperative Complications; Respiration, Artificial; Respiratory Insufficiency; Sulfonamides; Tongue Neoplasms | 2006 |